NF-κB inhibitors stabilize the mRNA of high-affinity type-2 cationic amino acid transporter in LPS-stimulated rat liver

作者: C.-H. Yang , P.-S. Tsai , J.-J. Lee , C.-H. Huang , C.-J. Huang

DOI: 10.1111/J.1399-6576.2005.00660.X

关键词: IsozymeStimulationEndocrinologyNitric oxide synthaseMRNA destabilizationLiver injuryAmino acid transporterLipopolysaccharideBiologyInternal medicineNitric oxide

摘要: Background:  Induction of inducible nitric oxide synthase (iNOS) results in (NO) overproduction during endotoxemia. Cellular uptake l-arginine, modulated by the isozymes type-2 cationic amino acid transporters (CAT), including CAT-2, CAT-2A and CAT-2B, has been reported to be a crucial factor regulation iNOS activity. We sought elucidate expression CAT-2 role nuclear factor-κB (NF-κB) this lipopolysaccharide (LPS)-treated rat liver. Methods:  Adult male Sprague–Dawley rats were randomly given intravenous (i.v.) injections normal saline (N/S), LPS, LPS preceded an NF-κB inhibitor (PDTC, dexamethasone or salicylate) alone. After injection, sacrificed at different times enzyme liver injury examined. Hepatic systemic NO production also measured. Results:  CAT-2B constitutively expressed un-stimulated liver. stimulation not only significantly increased mRNA concentrations but decreased CAT-2A, time-dependent manner. LPS-induced hepatic was associated with hepatocellular injury. Pre-treatment inhibitors attenuated induction as well CAT-2/CAT-2B destabilization, which significant inhibition biosynthesis less injury. Conclusion:  stabilize LPS-stimulated The pathway may constitutive part cytoprotective mechanisms against sepsis.

参考文章(30)
R G Bogle, A R Baydoun, J D Pearson, S Moncada, G E Mann, L-arginine transport is increased in macrophages generating nitric oxide. Biochemical Journal. ,vol. 284, pp. 15- 18 ,(1992) , 10.1042/BJ2840015
Francois BLACHIER, Hamida M'RABET-TOUIL, Leta POSHO, Beatrice DARCY-VRILLON, Pierre-Henri DUEE, Intestinal arginine metabolism during development. Evidence for de novo synthesis of L-arginine in newborn pig enterocytes. FEBS Journal. ,vol. 216, pp. 109- 117 ,(1993) , 10.1111/J.1432-1033.1993.TB18122.X
Carl Nathan, Nitric oxide as a secretory product of mammalian cells. The FASEB Journal. ,vol. 6, pp. 3051- 3064 ,(1992) , 10.1096/FASEBJ.6.12.1381691
Burkhard Hinz, Kay Brune, Andreas Pahl, Nitric Oxide Inhibits Inducible Nitric Oxide Synthase mRNA Expression in RAW 264.7 Macrophages Biochemical and Biophysical Research Communications. ,vol. 271, pp. 353- 357 ,(2000) , 10.1006/BBRC.2000.2632
Hartmut Ruetten, Garry J. Southan, Aida Abate, Christoph Thiemermann, Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. British Journal of Pharmacology. ,vol. 118, pp. 261- 270 ,(1996) , 10.1111/J.1476-5381.1996.TB15397.X
David A. Geller, Stanley H. Chia, Yoshihito Takahashi, Gautam P. Yagnik, George Tsoulfas, Noriko Murase, Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation. Journal of Parenteral and Enteral Nutrition. ,vol. 25, pp. 142- 147 ,(2001) , 10.1177/0148607101025003142
Jane A. Mitchell, Markus Hecker, John R. Vane, The generation of L-arginine in endothelial cells is linked to the release of endothelium-derived relaxing factor. European Journal of Pharmacology. ,vol. 176, pp. 253- 254 ,(1990) , 10.1016/0014-2999(90)90541-D
D. A. Geller, A. K. Nussler, M. Di Silvio, C. J. Lowenstein, R. A. Shapiro, S. C. Wang, R. L. Simmons, T. R. Billiar, Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 522- 526 ,(1993) , 10.1073/PNAS.90.2.522
Ken. M. Kengatharan, Sjef J. Kimpe, Christoph Thiemermann, Role of nitric oxide in the circulatory failure and organ injury in a rodent model of Gram-positive shock British Journal of Pharmacology. ,vol. 119, pp. 1411- 1421 ,(1996) , 10.1111/J.1476-5381.1996.TB16053.X